CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+5.12%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$5.78B
AUM Growth
+$56.1M
(+0.98%)
Cap. Flow
-$211M
Cap. Flow
% of AUM
-3.66%
Top 10 Holdings %
Top 10 Hldgs %
16.17%
Holding
798
New
72
Increased
310
Reduced
286
Closed
45
Top Buys
| 1 |
Amgen
AMGN
|
+$28M |
| 2 |
Meta Platforms (Facebook)
META
|
+$25.9M |
| 3 |
Southwest Airlines
LUV
|
+$18.5M |
| 4 |
Travelers Companies
TRV
|
+$17.6M |
| 5 |
Cigna
CI
|
+$16.9M |
Top Sells
| 1 |
Biogen
BIIB
|
+$75.9M |
| 2 |
Johnson & Johnson
JNJ
|
+$27.9M |
| 3 |
Gilead Sciences
GILD
|
+$25M |
| 4 |
Neurocrine Biosciences
NBIX
|
+$22.7M |
| 5 |
Amazon
AMZN
|
+$21.4M |
Sector Composition
| 1 | Healthcare | 22.62% |
| 2 | Technology | 14.66% |
| 3 | Financials | 14.55% |
| 4 | Consumer Discretionary | 9.89% |
| 5 | Communication Services | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
526
Align Technology
ALGN
$9.92B
| $1.26M | 0.02% |
+5,680
| New | +$1.26M |
|
527
Eastman Chemical
EMN
$7.91B
| $1.26M | 0.02% |
13,604
+1,275
| +10% | +$118K |
|
|
ACHN
528
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $1.25M | 0.02% |
435,000
-5,000
| -1% | -$14.4K |
|
|
CDK
529
DELISTED
CDK Global, Inc.
CDK
| $1.25M | 0.02% |
17,560
| – | – |
|
530
Genuine Parts
GPC
$19.5B
| $1.25M | 0.02% |
13,153
-1,216
| -8% | -$116K |
|
531
Intellia Therapeutics
NTLA
$1.27B
| $1.25M | 0.02% |
+65,000
| New | +$1.25M |
|
532
Brown-Forman Class B
BF.B
$13B
| $1.24M | 0.02% |
28,313
+4,682
| +20% | +$206K |
|
533
Bunge Global
BG
$16.9B
| $1.24M | 0.02% |
18,540
+9,407
| +103% | +$631K |
|
534
Cintas
CTAS
$81.7B
| $1.24M | 0.02% |
31,900
-7,508
| -19% | -$293K |
|
|
VAR
535
DELISTED
Varian Medical Systems, Inc.
VAR
| $1.24M | 0.02% |
11,186
+1,456
| +15% | +$162K |
|
|
CBAY
536
DELISTED
Cymabay Therapeutics
CBAY
| $1.24M | 0.02% |
+135,000
| New | +$1.24M |
|
537
Coherus Oncology, Inc. Common Stock
CHRS
$159M
| $1.24M | 0.02% |
141,000
-52,000
| -27% | -$458K |
|
538
Hershey
HSY
$38B
| $1.24M | 0.02% |
10,935
+1,034
| +10% | +$117K |
|
|
DBVT
539
DBV Technologies
DBVT
$238M
| $1.23M | 0.02% |
+5,000
| New | +$1.23M |
|
540
Entergy
ETR
$38.8B
| $1.22M | 0.02% |
29,922
-1,388
| -4% | -$56.5K |
|
541
TherapeuticsMD
TXMD
$12.5M
| $1.21M | 0.02% |
4,000
-6,600
| -62% | -$1.99M |
|
542
LG Display
LPL
$4.41B
| $1.2M | 0.02% |
87,000
+7,000
| +9% | +$96.3K |
|
543
Invesco India ETF
PIN
$211M
| $1.19M | 0.02% |
+45,000
| New | +$1.19M |
|
544
Celanese
CE
$5.09B
| $1.18M | 0.02% |
11,048
-3,254
| -23% | -$348K |
|
545
C.H. Robinson
CHRW
$14.9B
| $1.18M | 0.02% |
13,281
-681
| -5% | -$60.7K |
|
|
ELGX
546
DELISTED
Endologix Inc
ELGX
| $1.18M | 0.02% |
22,000
| – | – |
|
547
International Flavors & Fragrances
IFF
$17B
| $1.17M | 0.02% |
7,688
+515
| +7% | +$78.6K |
|
548
Northrop Grumman
NOC
$83.3B
| $1.17M | 0.02% |
3,812
-12,125
| -76% | -$3.72M |
|
549
HF Sinclair
DINO
$9.56B
| $1.17M | 0.02% |
22,752
-3,649
| -14% | -$187K |
|
|
ALDR
550
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $1.16M | 0.02% |
101,000
-16,000
| -14% | -$183K |
|